AT374681B - Verfahren zur herstellung pharmazeutischer zusammensetzungen in tablettenform - Google Patents

Verfahren zur herstellung pharmazeutischer zusammensetzungen in tablettenform

Info

Publication number
AT374681B
AT374681B AT0005481A AT5481A AT374681B AT 374681 B AT374681 B AT 374681B AT 0005481 A AT0005481 A AT 0005481A AT 5481 A AT5481 A AT 5481A AT 374681 B AT374681 B AT 374681B
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
tablet form
producing pharmaceutical
producing
tablet
Prior art date
Application number
AT0005481A
Other languages
English (en)
Other versions
ATA5481A (de
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/194,453 external-priority patent/US4308251A/en
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of ATA5481A publication Critical patent/ATA5481A/de
Application granted granted Critical
Publication of AT374681B publication Critical patent/AT374681B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT0005481A 1980-01-11 1981-01-09 Verfahren zur herstellung pharmazeutischer zusammensetzungen in tablettenform AT374681B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11143080A 1980-01-11 1980-01-11
US06/194,453 US4308251A (en) 1980-01-11 1980-10-17 Controlled release formulations of orally-active medicaments

Publications (2)

Publication Number Publication Date
ATA5481A ATA5481A (de) 1983-10-15
AT374681B true AT374681B (de) 1984-05-25

Family

ID=26808896

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0005481A AT374681B (de) 1980-01-11 1981-01-09 Verfahren zur herstellung pharmazeutischer zusammensetzungen in tablettenform

Country Status (22)

Country Link
JP (1) JPS56103110A (de)
AT (1) AT374681B (de)
AU (1) AU542824B2 (de)
BE (1) BE886998A (de)
CA (1) CA1140466A (de)
CH (1) CH646604A5 (de)
DE (1) DE3100191A1 (de)
DK (1) DK6181A (de)
ES (2) ES498369A0 (de)
FI (1) FI76927C (de)
FR (1) FR2473308B1 (de)
GB (1) GB2067072B (de)
GR (1) GR73843B (de)
IE (1) IE50806B1 (de)
IN (1) IN151913B (de)
IT (1) IT1221041B (de)
LU (1) LU83052A1 (de)
NL (1) NL8100037A (de)
NO (1) NO156153C (de)
NZ (1) NZ195933A (de)
SE (1) SE447450B (de)
ZA (1) ZA81136B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2496082A (en) * 1947-05-24 1950-01-31 Ashenfelter William Scaffold structure
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
JPS59227817A (ja) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd 持続性経口用ブレデニン製剤
JPH0662404B2 (ja) * 1983-06-14 1994-08-17 シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド 制御放出性ナプロキセンおよびナプロキセンナトリウム錠
ZA836030B (en) * 1983-08-16 1985-02-27 Verex Lab Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
ZA836031B (en) * 1983-08-16 1985-02-27 Verex Lab Constant release rate solid dosage theophylline formulation
EP0138216B1 (de) * 1983-10-14 1993-01-07 Sumitomo Pharmaceuticals Company, Limited IFN-Präparat mit verzögerter Abgabe für parentale Verabreichung
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
EP0230647B1 (de) * 1985-12-27 1993-03-31 Sumitomo Pharmaceuticals Company, Limited Verfahren zur Herstellung einer Formulierung mit verzögerter Freisetzung
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
CA1316110C (en) * 1987-02-27 1993-04-13 Peter Lloyd Oren Sustained release matrix formulations
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
US5855915A (en) * 1995-06-30 1999-01-05 Baylor University Tablets or biologically acceptable implants for long-term antiinflammatory drug release

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2953497A (en) * 1953-06-03 1960-09-20 Howard A Press Therapeutic tablets
NL265428A (de) * 1960-06-06
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS5411226A (en) * 1977-06-24 1979-01-27 Shin Etsu Chem Co Ltd Disintegratable granule

Also Published As

Publication number Publication date
NO156153B (no) 1987-04-27
FI76927C (fi) 1989-01-10
AU542824B2 (en) 1985-03-14
NO810062L (no) 1981-07-13
SE8100104L (sv) 1981-07-12
ATA5481A (de) 1983-10-15
NZ195933A (en) 1982-11-23
FR2473308A1 (fr) 1981-07-17
DK6181A (da) 1981-07-12
FI810056L (fi) 1981-07-12
ES509179A0 (es) 1982-12-16
AU6597681A (en) 1981-07-16
ES8205353A1 (es) 1982-06-01
IN151913B (de) 1983-09-03
DE3100191A1 (de) 1981-12-10
NL8100037A (nl) 1981-08-03
FR2473308B1 (fr) 1985-07-19
BE886998A (fr) 1981-07-08
FI76927B (fi) 1988-09-30
IE50806B1 (en) 1986-07-23
ES498369A0 (es) 1982-06-01
NO156153C (no) 1987-08-05
GB2067072A (en) 1981-07-22
IT8147537A0 (it) 1981-01-09
LU83052A1 (fr) 1982-09-10
ES8301629A1 (es) 1982-12-16
GB2067072B (en) 1983-08-10
IE810036L (en) 1981-07-11
DE3100191C2 (de) 1988-09-01
SE447450B (sv) 1986-11-17
ZA81136B (en) 1982-01-27
GR73843B (de) 1984-05-07
IT1221041B (it) 1990-06-21
JPS56103110A (en) 1981-08-18
CA1140466A (en) 1983-02-01
CH646604A5 (fr) 1984-12-14

Similar Documents

Publication Publication Date Title
AT373146B (de) Verfahren zur herstellung von tabletten
AT360654B (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
AT383271B (de) Verfahren zur herstellung von cerebralwirksamen arzneimitteln
AT373777B (de) Verfahren zur herstellung antiherpetisch wirksamer topischer arzneimittelformen
AT371708B (de) Verfahren zur herstellung von pharmazeutischen einheitsdosierungsformen
AT381639B (de) Verfahren zur herstellung pharmazeutischer tabletten mit verzoegerter wirkstofffreigabe
ATA420581A (de) Verfahren zur herstellung von pyrimidonderivaten
AT374681B (de) Verfahren zur herstellung pharmazeutischer zusammensetzungen in tablettenform
AT381025B (de) Verfahren zur herstellung von topischen pharmazeutischen zubereitungen
AT375016B (de) Verfahren zur herstellung eines mundpflegemittels
AT367295B (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
AT376366B (de) Verfahren zur herstellung eines arzneimittels
AT374682B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
AT373123B (de) Verfahren zur herstellung von karamelpraeparaten in trockener gepulverter form
AT363086B (de) Verfahren zur herstellung neuer benzopyranderivate
AT380005B (de) Verfahren zur herstellung von gipsprodukten
AT365452B (de) Verfahren zur herstellung pharmazeutischer praeparate
AT374365B (de) Verfahren zur herstellung eines pharmazeutischen praeparates
AT380789B (de) Verfahren zur herstellung von theophyllintabletten
ATA328780A (de) Verfahren zur herstellung acylaminobenzoesaeurecerivaten
AT383272B (de) Verfahren zur herstellung von pharmazeutischen tabletten
AT374828B (de) Verfahren zur herstellung von humaninterferon
AT371710B (de) Verfahren zur herstellung galenischer zubereitungen
ATA295180A (de) Verfahren zur herstellung des neuen pivaloyloxymethyl-2-propylpentanoats e arzneimittel
AT370716B (de) Verfahren zur herstellung von naphthacendionderivaten

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee